首页> 外文期刊>Respiration: International Review of Thoracic Diseases >Role of chemical mediators in airway hyperresponsiveness in an asthmatic model.
【24h】

Role of chemical mediators in airway hyperresponsiveness in an asthmatic model.

机译:在哮喘模型中,化学介质在气道高反应性中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Airway hyperresponsiveness (AHR) is one of the characteristic features of human asthma. The presence of AHR and the precise mechanisms immediately after establishment of sensitization in guinea pigs are unclear, although there are many reports showing allergen exposure that causes an increase in bronchial responsiveness associated with eosinophil influx into the airway in sensitized guinea pigs. OBJECTIVE: We investigated the inhibitory effects on AHR to histamine of ONO-1078, a leukotriene antagonist; indomethacin, a cyclooxygenase inhibitor; S-145, a thromboxane A(2) (TXA(2)) antagonist, and Y-24180, a platelet-activating factor (PAF) antagonist, to assess the involvement of chemical mediators in AHR employing ovalbumin (OA) sensitized guinea pig models. METHODS: Male Hartley guinea pigs were used. Each group comprised 4-7 animals. The animals were sensitized to OA, injecting intraperitoneally 30 mg of cyclophosphamide and 2,000 microg of OA together with 100 mg of aluminum hydroxide as the adjuvant. The guinea pigs were artificially ventilated via a cannula using a small-animal respirator after intraperitoneal anesthesia with pentobarbital sodium for tracheotomy. The pressure at the airway opening (PAO) was measured using a differential pressure transducer, and a differential pressure of peak PAO (peak DeltaPAO) at inspiratory phase as an overall index of bronchial response to bronchoactive agents was used. While being artificially ventilated, the animals were exposed to physiological saline solution containing various concentrations of histamine (4.9, 9.8, 20, 39, 78, and 156 microg/ml) by inhalation for 30 s at 3-min intervals. Determinations were made at 1 min after each inhalation. The chemical mediators were each (30 mg/kg of ONO-1078, 3 mg/kg of S-1452, and 1 mg/kg of Y-24180) administered orally to sensitized guinea pigs, and the airway response to histamine was assessed. Each group comprised 4-7 animals. RESULTS: The airway response to histamine was significantly greater in the sensitized group than in the nonsensitized group at histamine concentrations of 36 (p < 0.05), 78, and 156 mg/ml (p < 0.01). Leukotrienes C(4) and D(4): 30 mg/kg of ONO-178 did not show any inhibitory effect on airway response to inhaled histamine. Cyclooxygenase: 5 mg/kg of indomethacin did not show any inhibitory effect on the airway response to inhaled histamine. TXA(2): the AHR to inhaled histamine at doses of 9.8, 39, 78, and 156 microg/ml was significantly inhibited by prior administration of 3 mg/kg of S-1452. PAF: the AHR to inhaled histamine at doses of 9.8, 39, and 78 microg/ml was significantly inhibited by prior administration of 1 mg/kg of Y-24180. CONCLUSIONS: S-1452 (3 mg/kg) and Y-24180 (1 mg/kg) significantly inhibited AHR to histamine, while ONO-108 (30 mg/kg) and indomethacin (5 mg/kg) did not. The results suggest that TXA(2) and PAF are involved in AHR in OA-sensitized guinea pigs. Copyright 2001 S. Karger AG, Basel
机译:背景:气道高反应性(AHR)是人类哮喘的特征之一。豚鼠致敏后立即存在AHR及其确切机制尚不清楚,尽管有许多报道显示过敏原暴露会导致致敏性豚鼠向嗜酸性粒细胞流入气道的支气管反应性增加。目的:研究白三烯拮抗剂ONO-1078对组胺的抑制作用。消炎痛,一种环氧合酶抑制剂; S-145,血栓烷A(2)(TXA(2))拮抗剂,和Y-24180,血小板活化因子(PAF)拮抗剂,用于评估使用卵清蛋白(OA)致敏豚鼠的AHR中的化学介质的参与楷模。方法:使用雄性哈特利豚鼠。每组包括4-7只动物。使动物对OA敏感,腹膜内注射30mg的环磷酰胺和2,000μg的OA以及100mg的氢氧化铝作为佐剂。腹腔内麻醉后用戊巴比妥钠进行气管切开术,使用小型动物呼吸器对豚鼠进行人工通气。使用压差传感器测量气道开口处的压力(PAO),并使用吸气时峰PAO的压差(peak DeltaPAO)作为支气管对支气管活性剂反应的总体指标。在人工通风的情况下,将动物以3分钟的间隔吸入30 s,使其暴露于含有各种浓度的组胺(4.9、9.8、20、39、78和156 microg / ml)的生理盐水溶液中。每次吸入后1分钟进行测定。分别对致敏的豚鼠口服施用化学介质(30 mg / kg的ONO-1078、3 mg / kg的S-1452和1 mg / kg的Y-24180),并评估其对组胺的气道反应。每组包括4-7只动物。结果:在组胺浓度分别为36(p <0.05),78和156 mg / ml(p <0.01)的情况下,致敏组的气道对组胺的反应明显大于未致敏组。白三烯C(4)和D(4):30 mg / kg的ONO-178对吸入的组胺对气道反应没有抑制作用。环氧合酶:吲哚美辛5 mg / kg对吸入组胺的气道反应没有抑制作用。 TXA(2):事先给予3 mg / kg的S-1452可以明显抑制以9.8、39、78和156 microg / ml剂量吸入组胺的AHR。 PAF:事先给予1 mg / kg的Y-24180可以明显抑制以9.8、39和78 microg / ml剂量吸入组胺的AHR。结论:S-1452(3 mg / kg)和Y-24180(1 mg / kg)显着抑制AHR对组胺的抑制作用,而ONO-108(30 mg / kg)和消炎痛(5 mg / kg)则没有。结果表明TXA(2)和PAF参与OA致敏豚鼠的AHR。版权所有2001 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号